Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)

2019-04-29T19:01:48+00:00August 9th, 2017|Categories: Publications|Tags: , , , |

VIEW PUBLICATION ⟶